/

Empresas

Br

No verificado

Brenus Pharma

Sobre qué escribimos

BiotecnologíaCienciaIndustriaOncologíaSalud

13 Comunicados de prensa

Ver todos los comunicados de prensa

27/05/2026

Ciencia

Higiene alimentaria

Medicina - Varios

Sanidad

Biotecnología

Farmacéutica

Salud

Oncología

Industria

Eventos

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)

Fuente

Editor

1.00

0

14/04/2026

Eventos

Ferias y Congresos

Industria

Oncología

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

AACR 2026: First‑in‑Human STC‑1010 Data Show Favorable Safety and Early Immune Engagement in Metastatic MSS Colorectal Cancer

Fuente

Editor

1.00

0

19/02/2026

Ciencia

Biotecnología

Farmacéutica

Oncología

Salud

Eventos

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

Fuente

Editor

1.00

0

06/01/2026

Industria

Ciencia

Medicina - Varios

Biotecnología

Salud

Farmacéutica

Sanidad

Oncología

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients

Fuente

Editor

1.00

0

12/11/2025

Oncología

Salud

Ciencia

Sanidad

Biotecnología

Eventos

Mercado laboral

Industria

Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn

Fuente

Editor

1.00

0

02/09/2025

Industria

Ciencia

Biotecnología

Farmacéutica

Oncología

Sanidad

Salud

Medicina - Varios

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

Fuente

Editor

1.00

0

19/06/2025

Ciencia

Biotecnología

Oncología

Salud

Material médico sanitario

Sanidad

Industria

Eventos

Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking in vivo Human Colorectal Cancer Conditions and Confirming STC-1010’s Efficacy

Fuente

Editor

1.00

0

07/05/2025

AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

Fuente

Editor

1.00

0

07/11/2024

Multimedia

Industria

Ciencia

Biotecnología

Farmacéutica

Oncología

Salud

Medicina - Varios

Sanidad

Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1)

Fuente

Editor

1.00

0

18/09/2024

Industria

Oncología

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Brenus Pharma Raises $25 Million to Accelerate Clinical Trials of Its Precision Cancer Vaccines.

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0